COMMUNIQUÉS West-GlobeNewswire

Taconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping Services
14/08/2017
HUDSON, N.Y., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Cergentis B.V [...]
Novo Nordisk A/S - Share repurchase programme
14/08/2017
Bagsværd, Denmark, 14 Aug 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Ossur Hf : Major shareholder announcement
14/08/2017
Enclosed notification of a major shareholder announcement Major Shareholder Announcement This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer [...]
Completion of the initial public offering of American Depositary Shares and registration of capital increase
14/08/2017
Company announcement - No. 35/2017 Zealand Pharma A/S has today registered a capital increase of 4,375,000 new shares and completed its initial public offering of American Depositary Shares on the Nasdaq Global Select [...]
William Demant Holding A/S: Interim Report 2017
14/08/2017
Company announcement no 2017-07 Interim Report 2017 14 August 2017 Market share gains in wholesale of hearing aids, with organic growth of 11% driven by Oticon Opn Group organic growth of 8% due to innovative products [...]
Saniona AB: Saniona's partner, Luc Therapeutics, nominates clinical candidate and initiates preclinical development in joint Ataxia program
14/08/2017
PRESS RELEASE 14 August 2017 Saniona, a leading biotech company in the field of ion channels, today announces that its collaboration partner, Luc Therapeutics, has initiated preclinical development for the drug [...]
Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August
14/08/2017
Oslo, Norway, 14 August 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its second quarter and first half 2017 results on [...]
Corbion reports transactions under its current share buyback program
14/08/2017
Corbion has repurchased 49,850 of its own common shares in the period from August 7, 2017 up to and including August 11, 2017 at an average price of € 25.87 per share. The consideration of the repurchase was € 1.29 [...]
Crown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations
14/08/2017
SANTA CLARA, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]
Sanofi : Disclosure of trading in own shares
11/08/2017
Disclosure of trading in own shares This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]
Sanofi : Déclaration des transactions sur actions propres
11/08/2017
Déclaration des transactions sur actions propres This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they [...]
RAMSAY GENERALE DE SANTE : AMENDEMENT ET EXTENSION DE LA CONVENTION DE CREDIT SENIOR
11/08/2017
Paris, le 11 août 2017 « Communiqué de Presse » Ramsay Générale de Santé Amendement et extension de la convention de crédit senior Ramsay Générale de Santé, leader de l'hospitalisation privée en France a finalisé avec [...]
RAMSAY GENERALE DE SANTE : AMEND AND EXTEND OF ITS SENIOR FACILITIES AGREEMENT
11/08/2017
Paris, 11th August 2017 « Press Release » Ramsay Générale de Santé Amend and Extend of its Senior Facilities Agreement Ramsay Générale de Santé, the leading private hospital group in France, on 11 August 2017 [...]
ProMIS Neurosciences Announces Second Quarter 2017 Results
11/08/2017
TORONTO and CAMBRIDGE, Mass., Aug. 11, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (" ProMIS " or the " Company "), a company focused on the discovery and development of precision treatments for [...]
PCI Biotech: First patient dosed in the fimaCHEM Phase I extension study
11/08/2017
Oslo, 11 August 2017 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the first patient has been dosed in the fima Chem Phase I extension study with the objective to evaluate [...]
Notice of Nexstim Plc's Half-Yearly Report H1 2017
11/08/2017
Company announcement, Helsinki, 11 August 2017 at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]
ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017
11/08/2017
Zutphen, The Netherlands, 11 August 2017 As of today, EUR 2,090,000 of notes out of the total commitment amounting to EUR 9 million have been converted into shares and EUR 250,000 of warrants out of a total potential [...]
ABLYNX ANNOUNCES WARRANT EXERCISE
11/08/2017
REGULATED INFORMATION GHENT, Belgium, 11 August 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]
EDAP-TMS to Announce Second Quarter 2017 Financial Results on Wednesday, August 23, 2017
10/08/2017
PRESS RELEASE Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital EDAP-TMS to Announce Second [...]

Pages